Oncolytics plans FDA talks for pancreatic cancer drug trial
Go back to Oncolytics plans FDA talks for pancreatic cancer drug trial| Bank of Commerce (NASDAQ: ONC) | Delayed: 372.78 +3.63 (0.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $369.15 | 52 Week High | $0.35 | |||
| Open | $372.25 | 52 Week Low | $0.35 | |||
| Day High | $374.79 | P/E | N/A | |||
| Day Low | $371.05 | EPS | $0.00 | |||
| Volume | 14,896 | |||||
| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.85 +0.01 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.84 | 52 Week High | $1.37 | |||
| Open | $0.85 | 52 Week Low | $0.24 | |||
| Day High | $0.86 | P/E | N/A | |||
| Day Low | $0.84 | EPS | $0.00 | |||
| Volume | 63,581 | |||||
